blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1667711

EP1667711 - PREVENTIVE CANCER VACCINE BASED ON BROTHER OF REGULATOR OF IMPRINTED SITES MOLECULE (BORIS) [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.06.2011
Database last updated on 07.10.2024
Most recent event   Tooltip05.07.2013Lapse of the patent in a contracting state
New state(s): PT		published on 07.08.2013  [2013/32]
Applicant(s)For all designated states
UniVax, LLC
1611 N. San Fernando Blvd., Suite D
Burbank, CA 91504 / US
[2010/23]
Former [2010/22]For all designated states
Vendevia Group, LLC
3440 Hollywood Boulevard Suite 100
Hollywood, FL 33160 / US
Former [2006/27]For all designated states
OncoMune
290 North West 165th Street Suite P350
Miami, Florida 33169 / US
Former [2006/24]For all designated states
Agadjanyan, Michael G.
16371 Gothard Street, Unit H
Huntington Beach, CA 92647 / US
For all designated states
Ghochikyan, Anahit
16371 Gothard Street, Unit H
Huntington Beach, CA 92647 / US
Inventor(s)01 / AGADJANYAN, Michael G.
c/o Departement of Molecular Immunology, Institute for Molecular Medecine 16371 Gothard Street, Unit H
Huntington Beach, CA 92647 / US
02 / GHOCHIKYAN, Anahit
c/o Departement of Molecular Immunology, Institute for Molecular Medecine 16371 Gothard Street, Unit H
Huntindton Beach, CA 92647 / US
 [2010/09]
Former [2006/24]01 / see applicant
...
Representative(s)Elsy, David, et al
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[N/P]
Former [2006/24]Elsy, David, et al
Withers & Rogers LLP Goldings House, 2 Hays Lane
London SE1 2HW / GB
Application number, filing date04782353.925.08.2004
[2006/24]
WO2004US27856
Priority number, dateUS20030497511P25.08.2003         Original published format: US 497511 P
[2006/24]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005021029
Date:10.03.2005
Language:EN
[2005/10]
Type: A2 Application without search report 
No.:EP1667711
Date:14.06.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 10.03.2005 takes the place of the publication of the European patent application.
[2006/24]
Type: B1 Patent specification 
No.:EP1667711
Date:28.07.2010
Language:EN
[2010/30]
Search report(s)International search report - published on:EP26.05.2005
ClassificationIPC:A61K39/00, A61P35/00, C12N5/0784
[2010/08]
CPC:
C07K14/4748 (EP,US); A61K2239/31 (EP,US); A61K39/4615 (EP,US);
A61K39/4622 (EP,US); A61K39/464484 (EP,US); A61P35/00 (EP);
A61P37/02 (EP); C12N5/0639 (EP,US); A61K2039/5258 (EP,US);
A61K2039/53 (EP,US); A61K2039/55516 (EP,US); A61K2039/6075 (EP,US) (-)
Former IPC [2006/24]A61K39/00, A61P35/00, C12N5/08, C12N5/10
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/24]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:PRÄVENTIVE KREBSVAKZINE AUF BASIS DES BORIS (BROTHER OF REGULATOR OF IMPRINTED SITES) MOLEKÜLS[2006/24]
English:PREVENTIVE CANCER VACCINE BASED ON BROTHER OF REGULATOR OF IMPRINTED SITES MOLECULE (BORIS)[2006/24]
French:VACCIN PREVENTIF CONTRE LE CANCER A BASE DE MOLECULE BORIS (FRERE DU REGULATEUR DE SITES MARQUES)[2006/24]
Entry into regional phase23.03.2006National basic fee paid 
23.03.2006Designation fee(s) paid 
23.03.2006Examination fee paid 
Examination procedure25.03.2005Request for preliminary examination filed
International Preliminary Examining Authority: US
23.03.2006Amendment by applicant (claims and/or description)
23.03.2006Examination requested  [2006/24]
09.05.2007Despatch of a communication from the examining division (Time limit: M06)
16.11.2007Reply to a communication from the examining division
14.07.2008Despatch of a communication from the examining division (Time limit: M06)
16.01.2009Reply to a communication from the examining division
10.02.2010Communication of intention to grant the patent
16.06.2010Fee for grant paid
16.06.2010Fee for publishing/printing paid
Opposition(s)29.04.2011No opposition filed within time limit [2011/27]
Fees paidRenewal fee
25.08.2006Renewal fee patent year 03
29.08.2007Renewal fee patent year 04
28.03.2008Renewal fee patent year 05
25.08.2009Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE28.07.2010
CY28.07.2010
CZ28.07.2010
EE28.07.2010
FI28.07.2010
PL28.07.2010
PT28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
TR28.07.2010
IE25.08.2010
LU25.08.2010
MC31.08.2010
BG28.10.2010
GR29.10.2010
ES08.11.2010
HU29.01.2011
[2013/32]
Former [2012/47]BE28.07.2010
CY28.07.2010
CZ28.07.2010
EE28.07.2010
FI28.07.2010
PL28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
TR28.07.2010
IE25.08.2010
LU25.08.2010
MC31.08.2010
BG28.10.2010
GR29.10.2010
ES08.11.2010
HU29.01.2011
Former [2012/44]BE28.07.2010
CY28.07.2010
CZ28.07.2010
EE28.07.2010
FI28.07.2010
PL28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
IE25.08.2010
LU25.08.2010
MC31.08.2010
BG28.10.2010
GR29.10.2010
ES08.11.2010
HU29.01.2011
Former [2012/42]BE28.07.2010
CY28.07.2010
CZ28.07.2010
EE28.07.2010
FI28.07.2010
PL28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
IE25.08.2010
MC31.08.2010
BG28.10.2010
GR29.10.2010
ES08.11.2010
HU29.01.2011
Former [2011/36]BE28.07.2010
CY28.07.2010
CZ28.07.2010
EE28.07.2010
FI28.07.2010
PL28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
IE25.08.2010
MC31.08.2010
BG28.10.2010
GR29.10.2010
ES08.11.2010
Former [2011/32]BE28.07.2010
CY28.07.2010
CZ28.07.2010
EE28.07.2010
FI28.07.2010
PL28.07.2010
RO28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
MC31.08.2010
BG28.10.2010
GR29.10.2010
ES08.11.2010
Former [2011/23]BE28.07.2010
CY28.07.2010
CZ28.07.2010
EE28.07.2010
FI28.07.2010
PL28.07.2010
SE28.07.2010
SI28.07.2010
SK28.07.2010
MC31.08.2010
BG28.10.2010
GR29.10.2010
Former [2011/16]BE28.07.2010
CY28.07.2010
FI28.07.2010
PL28.07.2010
SE28.07.2010
SI28.07.2010
MC31.08.2010
BG28.10.2010
GR29.10.2010
Former [2011/15]CY28.07.2010
FI28.07.2010
PL28.07.2010
SE28.07.2010
SI28.07.2010
MC31.08.2010
BG28.10.2010
GR29.10.2010
Former [2011/13]CY28.07.2010
FI28.07.2010
PL28.07.2010
SI28.07.2010
BG28.10.2010
Former [2011/11]FI28.07.2010
PL28.07.2010
SI28.07.2010
BG28.10.2010
Cited inInternational search[PX]WO03072799  (US GOV HEALTH & HUMAN SERV [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.